Previous close | 67.10 |
Open | 67.79 |
Bid | 63.00 x 800 |
Ask | 69.67 x 800 |
Day's range | 66.73 - 68.14 |
52-week range | 62.11 - 118.34 |
Volume | |
Avg. volume | 2,349,431 |
Market cap | 17.153B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -8.63 |
Earnings date | 06 Nov 2023 - 10 Nov 2023 |
Forward dividend & yield | 3.24 (4.82%) |
Ex-dividend date | 21 Sept 2023 |
1y target est | 77.56 |
IFF's Pharma Solutions and Health teams will showcase their extensive portfolios of next-level, plant-based dietary supplement solutions and innovative combination products that address some of today's most in-demand health applications, at SupplySide West Expo in Las Vegas, Nevada, booth #3265. Among IFF's latest innovations is its groundbreaking carrageenan-free vegan softgel technology, VERDIGEL™ SC.
Key Insights Using the 2 Stage Free Cash Flow to Equity, International Flavors & Fragrances fair value estimate is...
IFF (NYSE: IFF) will illustrate its product design capabilities, showcasing innovation expertise from ideation to commercialization, with insights-led food and beverage prototypes at the Food Tech® Summit & Expo in Mexico City from Sept. 27 to 28. With advanced insights and leveraging its industry-leading expertise in product development and creating unique taste experiences, the Company will demonstrate how its novel product design approach can stimulate future food and beverage creation.